nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CYP2C19—Methimazole—Graves' disease	0.172	0.674	CbGbCtD
Zonisamide—CYP3A4—Methimazole—Graves' disease	0.083	0.326	CbGbCtD
Zonisamide—Neuritis—Methimazole—Graves' disease	0.0207	0.0669	CcSEcCtD
Zonisamide—Neuritis—Propylthiouracil—Graves' disease	0.0176	0.0569	CcSEcCtD
Zonisamide—SCN1B—adipose tissue—Graves' disease	0.0171	0.0392	CbGeAlD
Zonisamide—CA10—pituitary gland—Graves' disease	0.0165	0.0377	CbGeAlD
Zonisamide—SCN2B—thyroid gland—Graves' disease	0.0164	0.0375	CbGeAlD
Zonisamide—CA8—pituitary gland—Graves' disease	0.0161	0.037	CbGeAlD
Zonisamide—CA8—adipose tissue—Graves' disease	0.0161	0.0369	CbGeAlD
Zonisamide—SCN3B—pituitary gland—Graves' disease	0.0158	0.0363	CbGeAlD
Zonisamide—SCN3B—adipose tissue—Graves' disease	0.0158	0.0362	CbGeAlD
Zonisamide—Liver injury—Propylthiouracil—Graves' disease	0.0156	0.0504	CcSEcCtD
Zonisamide—SCN1B—thyroid gland—Graves' disease	0.0148	0.0339	CbGeAlD
Zonisamide—Aplastic anaemia—Methimazole—Graves' disease	0.0145	0.0469	CcSEcCtD
Zonisamide—CA8—thyroid gland—Graves' disease	0.0139	0.0319	CbGeAlD
Zonisamide—CA13—adipose tissue—Graves' disease	0.0138	0.0315	CbGeAlD
Zonisamide—SCN3B—thyroid gland—Graves' disease	0.0137	0.0313	CbGeAlD
Zonisamide—SCN4B—pituitary gland—Graves' disease	0.0135	0.0309	CbGeAlD
Zonisamide—SCN4B—adipose tissue—Graves' disease	0.0134	0.0308	CbGeAlD
Zonisamide—Lymphadenopathy—Methimazole—Graves' disease	0.0131	0.0425	CcSEcCtD
Zonisamide—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0123	0.0399	CcSEcCtD
Zonisamide—CA13—thyroid gland—Graves' disease	0.0119	0.0273	CbGeAlD
Zonisamide—SCN4B—thyroid gland—Graves' disease	0.0116	0.0266	CbGeAlD
Zonisamide—CA11—pituitary gland—Graves' disease	0.0116	0.0266	CbGeAlD
Zonisamide—CA11—adipose tissue—Graves' disease	0.0116	0.0265	CbGeAlD
Zonisamide—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0112	0.0361	CcSEcCtD
Zonisamide—CA11—thyroid gland—Graves' disease	0.01	0.0229	CbGeAlD
Zonisamide—CA3—connective tissue—Graves' disease	0.00919	0.0211	CbGeAlD
Zonisamide—Neuropathy peripheral—Methimazole—Graves' disease	0.00845	0.0274	CcSEcCtD
Zonisamide—Agranulocytosis—Methimazole—Graves' disease	0.00805	0.0261	CcSEcCtD
Zonisamide—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00719	0.0233	CcSEcCtD
Zonisamide—CA3—pituitary gland—Graves' disease	0.00708	0.0162	CbGeAlD
Zonisamide—CA3—adipose tissue—Graves' disease	0.00705	0.0162	CbGeAlD
Zonisamide—Agranulocytosis—Propylthiouracil—Graves' disease	0.00684	0.0222	CcSEcCtD
Zonisamide—Alopecia—Methimazole—Graves' disease	0.00684	0.0222	CcSEcCtD
Zonisamide—CA12—eye—Graves' disease	0.00675	0.0155	CbGeAlD
Zonisamide—CA12—connective tissue—Graves' disease	0.00651	0.0149	CbGeAlD
Zonisamide—SCN9A—pituitary gland—Graves' disease	0.0063	0.0144	CbGeAlD
Zonisamide—SCN9A—adipose tissue—Graves' disease	0.00627	0.0144	CbGeAlD
Zonisamide—CA3—thyroid gland—Graves' disease	0.0061	0.014	CbGeAlD
Zonisamide—Vertigo—Methimazole—Graves' disease	0.00606	0.0196	CcSEcCtD
Zonisamide—Leukopenia—Methimazole—Graves' disease	0.00603	0.0195	CcSEcCtD
Zonisamide—CACNA1H—pituitary gland—Graves' disease	0.0059	0.0135	CbGeAlD
Zonisamide—Alopecia—Propylthiouracil—Graves' disease	0.00582	0.0188	CcSEcCtD
Zonisamide—Arthralgia—Methimazole—Graves' disease	0.00574	0.0186	CcSEcCtD
Zonisamide—Myalgia—Methimazole—Graves' disease	0.00574	0.0186	CcSEcCtD
Zonisamide—AOX1—eye—Graves' disease	0.00563	0.0129	CbGeAlD
Zonisamide—SCN4A—pituitary gland—Graves' disease	0.00562	0.0129	CbGeAlD
Zonisamide—Dysgeusia—Propylthiouracil—Graves' disease	0.00561	0.0182	CcSEcCtD
Zonisamide—SCN4A—adipose tissue—Graves' disease	0.00559	0.0128	CbGeAlD
Zonisamide—Oedema—Methimazole—Graves' disease	0.0055	0.0178	CcSEcCtD
Zonisamide—Thrombocytopenia—Methimazole—Graves' disease	0.00539	0.0174	CcSEcCtD
Zonisamide—CA1—eye—Graves' disease	0.00535	0.0123	CbGeAlD
Zonisamide—Vertigo—Propylthiouracil—Graves' disease	0.00515	0.0167	CcSEcCtD
Zonisamide—Leukopenia—Propylthiouracil—Graves' disease	0.00513	0.0166	CcSEcCtD
Zonisamide—CACNA1H—thyroid gland—Graves' disease	0.00509	0.0117	CbGeAlD
Zonisamide—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00501	0.0162	CcSEcCtD
Zonisamide—SCN2A—pituitary gland—Graves' disease	0.00497	0.0114	CbGeAlD
Zonisamide—Paraesthesia—Methimazole—Graves' disease	0.00494	0.016	CcSEcCtD
Zonisamide—Somnolence—Methimazole—Graves' disease	0.00489	0.0158	CcSEcCtD
Zonisamide—Arthralgia—Propylthiouracil—Graves' disease	0.00488	0.0158	CcSEcCtD
Zonisamide—Myalgia—Propylthiouracil—Graves' disease	0.00488	0.0158	CcSEcCtD
Zonisamide—SCN4A—thyroid gland—Graves' disease	0.00484	0.0111	CbGeAlD
Zonisamide—Dyspepsia—Methimazole—Graves' disease	0.00484	0.0157	CcSEcCtD
Zonisamide—Oedema—Propylthiouracil—Graves' disease	0.00468	0.0151	CcSEcCtD
Zonisamide—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00458	0.0148	CcSEcCtD
Zonisamide—CA5B—adipose tissue—Graves' disease	0.00448	0.0103	CbGeAlD
Zonisamide—Urticaria—Methimazole—Graves' disease	0.00437	0.0141	CcSEcCtD
Zonisamide—SCN3A—pituitary gland—Graves' disease	0.00437	0.01	CbGeAlD
Zonisamide—SCN3A—adipose tissue—Graves' disease	0.00435	0.00997	CbGeAlD
Zonisamide—Body temperature increased—Methimazole—Graves' disease	0.00435	0.0141	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00426	0.0138	CcSEcCtD
Zonisamide—Paraesthesia—Propylthiouracil—Graves' disease	0.0042	0.0136	CcSEcCtD
Zonisamide—MAOB—connective tissue—Graves' disease	0.00418	0.00959	CbGeAlD
Zonisamide—AOX1—pituitary gland—Graves' disease	0.00418	0.00958	CbGeAlD
Zonisamide—AOX1—adipose tissue—Graves' disease	0.00416	0.00955	CbGeAlD
Zonisamide—Somnolence—Propylthiouracil—Graves' disease	0.00416	0.0135	CcSEcCtD
Zonisamide—Dyspepsia—Propylthiouracil—Graves' disease	0.00412	0.0133	CcSEcCtD
Zonisamide—CA1—adipose tissue—Graves' disease	0.00395	0.00906	CbGeAlD
Zonisamide—Pruritus—Methimazole—Graves' disease	0.00389	0.0126	CcSEcCtD
Zonisamide—CA5B—thyroid gland—Graves' disease	0.00388	0.00888	CbGeAlD
Zonisamide—SCN3A—thyroid gland—Graves' disease	0.00377	0.00863	CbGeAlD
Zonisamide—Urticaria—Propylthiouracil—Graves' disease	0.00372	0.012	CcSEcCtD
Zonisamide—Body temperature increased—Propylthiouracil—Graves' disease	0.0037	0.012	CcSEcCtD
Zonisamide—AOX1—thyroid gland—Graves' disease	0.0036	0.00826	CbGeAlD
Zonisamide—MAOA—connective tissue—Graves' disease	0.00357	0.00818	CbGeAlD
Zonisamide—Vomiting—Methimazole—Graves' disease	0.0035	0.0113	CcSEcCtD
Zonisamide—Rash—Methimazole—Graves' disease	0.00347	0.0112	CcSEcCtD
Zonisamide—CA2—eye—Graves' disease	0.00347	0.00795	CbGeAlD
Zonisamide—Dermatitis—Methimazole—Graves' disease	0.00347	0.0112	CcSEcCtD
Zonisamide—Headache—Methimazole—Graves' disease	0.00345	0.0112	CcSEcCtD
Zonisamide—CA2—connective tissue—Graves' disease	0.00334	0.00766	CbGeAlD
Zonisamide—Pruritus—Propylthiouracil—Graves' disease	0.00331	0.0107	CcSEcCtD
Zonisamide—Nausea—Methimazole—Graves' disease	0.00327	0.0106	CcSEcCtD
Zonisamide—MAOB—pituitary gland—Graves' disease	0.00322	0.00739	CbGeAlD
Zonisamide—MAOB—adipose tissue—Graves' disease	0.00321	0.00736	CbGeAlD
Zonisamide—CA4—pituitary gland—Graves' disease	0.0031	0.00711	CbGeAlD
Zonisamide—CA4—adipose tissue—Graves' disease	0.00309	0.00708	CbGeAlD
Zonisamide—Vomiting—Propylthiouracil—Graves' disease	0.00297	0.00963	CcSEcCtD
Zonisamide—Rash—Propylthiouracil—Graves' disease	0.00295	0.00955	CcSEcCtD
Zonisamide—Dermatitis—Propylthiouracil—Graves' disease	0.00295	0.00954	CcSEcCtD
Zonisamide—Headache—Propylthiouracil—Graves' disease	0.00293	0.00949	CcSEcCtD
Zonisamide—Nausea—Propylthiouracil—Graves' disease	0.00278	0.009	CcSEcCtD
Zonisamide—MAOB—thyroid gland—Graves' disease	0.00278	0.00637	CbGeAlD
Zonisamide—MAOA—pituitary gland—Graves' disease	0.00275	0.0063	CbGeAlD
Zonisamide—MAOA—adipose tissue—Graves' disease	0.00274	0.00628	CbGeAlD
Zonisamide—CA4—thyroid gland—Graves' disease	0.00268	0.00613	CbGeAlD
Zonisamide—CA2—pituitary gland—Graves' disease	0.00257	0.0059	CbGeAlD
Zonisamide—CA2—adipose tissue—Graves' disease	0.00256	0.00587	CbGeAlD
Zonisamide—MAOA—thyroid gland—Graves' disease	0.00237	0.00543	CbGeAlD
Zonisamide—CA2—thyroid gland—Graves' disease	0.00222	0.00508	CbGeAlD
